Back to Results
First PageMeta Content
University of Alberta / Immunosuppressants / Academia / Education / Aaron E. Miller / James L. Vincent / Biogen Idec / Multiple sclerosis / IDEC


Leading the way in Multiple Sclerosis research November 5, 2014 A new Alberta-based research program aims to improve diagnosis and treatment for people with multiple sclerosis (Edmonton) Thousands of Albertans living wit
Add to Reading List

Document Date: 2014-11-05 17:17:45

Open Document

File Size: 130,87 KB

Share Result on Facebook

City

Edmonton / /

Company

Biogen Idec / /

Country

Canada / /

Currency

USD / /

Facility

University of Alberta’s Faculty / University of Alberta About / University of Alberta / /

IndustryTerm

hemophilia therapies / biotechnology / therapies for the treatment of neurodegenerative diseases / MS care / /

MedicalCondition

autoimmune disorders / disease / innovative hemophilia / Multiple Sclerosis / neurodegenerative diseases / MS / /

MedicalTreatment

innovative therapies / /

Organization

University of Alberta’s Faculty of Medicine & Dentistry / University of Alberta’s Faculty of Medicine / Government of Alberta / University of Alberta About / University of Alberta / Division of Neurology / /

Person

Fabrizio Giuliani / D. Douglas Miller / Len Walt / Don Scott / /

Position

leader / Minister / Director / Medical Affairs / Dean / Associate Professor / Medical Director / Medical Affairs / /

ProvinceOrState

Alberta / Mississippi / /

Technology

biotechnology / /

URL

www.med.ualberta.ca / www.biogenidec.com / /

SocialTag